Skip to main content

Advertisement

SpringerLink
Log in

Use of anti-thyroid drugs in patients with hyperthyroidism: a case for shared decision-making

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Struja T, Schuetz P. Use of radioactive iodine treatment in patients with hyperthyroidism? A case for shared decision making. Eur J Nucl Med Mol Imaging. 2019. https://doi.org/10.1007/s00259-019-04470-w.

  2. Kitahara CM, Berrington de Gonzalez A, Bouville A, et al. Association of radioactive iodine treatment with cancer mortality in patients with hyperthyroidism. JAMA Intern Med. 2019. https://doi.org/10.1001/jamainternmed.2019.0981.

  3. Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26:1343–421.

    Article  Google Scholar 

  4. Moeller LC, Führer D. Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective. Endocr Relat Cancer. 2013;20:19–29.

    Article  Google Scholar 

  5. Journy NMY, Bernier MO, Doody MM, et al. Hyperthyroidism, hypothyroidism, and cause-specific mortality in a large cohort of women. Thyroid. 2017;27:1001–10.

    Article  Google Scholar 

  6. Ron E, Doody MM, Becker DV, et al. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA. 1998;280:347–55.

    Article  CAS  Google Scholar 

  7. Ryödi E, Metso S, Jaatinen P, et al. Cancer incidence and mortality in patients treated either with RAI or thyroidectomy for hyperthyroidism. J Clin Endocrinol Metab. 2015;100:3710–7.

    Article  Google Scholar 

  8. Verburg FA, Luster M, Lassmann M, Reiners C. 131I therapy in patients with benign thyroid disease does not conclusively lead to a higher risk of subsequent malignancies. Nuklearmedizin. 2011;50:93–9.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinic for Nuclear Medicine and Thyroid Competence Centre, Imaging Institute of Southern Switzerland, Via Ospedale 6, CH-6500, Bellinzona, Switzerland

    Luca Giovanella

  2. Clinic for Nuclear Medicine, University Hospital and University of Zurich, Zurich, Switzerland

    Luca Giovanella

  3. Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany

    Frederik A. Verburg

Authors
  1. Luca Giovanella
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frederik A. Verburg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luca Giovanella.

Ethics declarations

Conflict of interest

L.G. is a member of Roche Diagnostics advisory board and has received research grants and speaker honoraria from Roche Diagnostics, IBSA, and Sanofi-Genzyme. F.A.V. has received research grants from Sanofi-Genzyme and speaker honoraria from Sanofi-Genzyme, Diasorin, and Jubilant Draximage.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Endocrinology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Giovanella, L., Verburg, F.A. Use of anti-thyroid drugs in patients with hyperthyroidism: a case for shared decision-making. Eur J Nucl Med Mol Imaging 46, 2408–2409 (2019). https://doi.org/10.1007/s00259-019-04476-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-019-04476-4

Search

Navigation